ESC 2014

Tous les comptes rendus

Diagnostic

02 sep 2014

Les causes de l’HTA secondaires résistantes

X. Jeunemaitre (France) – Secondary causes of resistant hypertension. Resistant hypertension in 2014.

Études d'intervention

02 sep 2014

Les modulateurs de la phospholipase A2 en difficulté

M. O’Donoghue (États-Unis) – The Stabilization Of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) trial : primary results – Hot Line : Coronary artery disease and lipids.

Études d'intervention

02 sep 2014

PARADIGM-HF : le changement, c’est maintenant !

M. Packer (États-Unis) – Results of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) – Hot Line : Cardiovascular disease : novel therapies.